Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$225.07 - $246.17 $439,561 - $480,770
-1,953 Reduced 80.54%
472 $110,000
Q1 2024

Apr 11, 2024

SELL
$233.45 - $247.73 $168,550 - $178,861
-722 Reduced 22.94%
2,425 $600,000
Q4 2023

Jan 09, 2024

BUY
$232.24 - $267.23 $491,419 - $565,458
2,116 Added 205.24%
3,147 $767,000
Q3 2023

Oct 10, 2023

BUY
$254.9 - $283.59 $79,273 - $88,196
311 Added 43.19%
1,031 $266,000
Q2 2023

Jul 13, 2023

BUY
$238.39 - $265.32 $19,547 - $21,756
82 Added 12.85%
720 $190,000
Q3 2022

Oct 20, 2022

SELL
$51.03 - $264.23 $41,130 - $212,969
-806 Reduced 55.82%
638 $142,000
Q2 2022

Jul 22, 2022

SELL
$234.74 - $275.42 $72,769 - $85,380
-310 Reduced 17.67%
1,444 $356,000
Q1 2022

Apr 18, 2022

SELL
$243.64 - $270.48 $19,003 - $21,097
-78 Reduced 4.26%
1,754 $467,000
Q4 2021

Jan 18, 2022

SELL
$230.08 - $250.94 $8,512 - $9,284
-37 Reduced 1.98%
1,832 $461,000
Q3 2021

Oct 19, 2021

SELL
$232.72 - $256.47 $41,656 - $45,908
-179 Reduced 8.74%
1,869 $459,000
Q4 2020

Jan 12, 2021

BUY
$221.92 - $245.94 $10,652 - $11,805
48 Added 2.4%
2,048 $512,000
Q3 2020

Oct 08, 2020

SELL
$215.77 - $276.76 $13,161 - $16,882
-61 Reduced 2.96%
2,000 $465,000
Q2 2020

Jul 15, 2020

SELL
$219.9 - $263.41 $288,508 - $345,593
-1,312 Reduced 38.9%
2,061 $493,000
Q1 2020

Apr 14, 2020

BUY
$195.69 - $279.01 $40,899 - $58,313
209 Added 6.61%
3,373 $850,000
Q1 2020

Apr 14, 2020

SELL
$195.69 - $279.01 $23,874 - $34,039
-122 Reduced 3.71%
3,164 $727,000
Q4 2019

Jan 13, 2020

SELL
$236.45 - $266.82 $3,310 - $3,735
-14 Reduced 0.42%
3,286 $894,000
Q3 2019

Oct 23, 2019

SELL
$230.58 - $256.08 $16,832 - $18,693
-73 Reduced 2.16%
3,300 $835,000
Q2 2019

Jul 16, 2019

SELL
$217.4 - $246.08 $224,791 - $254,446
-1,034 Reduced 23.46%
3,373 $850,000
Q1 2019

Apr 22, 2019

SELL
$206.05 - $248.17 $254,265 - $306,241
-1,234 Reduced 21.88%
4,407 $1.1 Million
Q4 2018

Jan 17, 2019

SELL
$204.73 - $257.93 $2,661 - $3,353
-13 Reduced 0.23%
5,641 $1.27 Million
Q3 2018

Nov 23, 2018

SELL
$233.07 - $256.0 $141,706 - $155,648
-608 Reduced 9.71%
5,654 $1.48 Million
Q2 2018

Jul 17, 2018

SELL
$208.1 - $233.85 $50,360 - $56,591
-242 Reduced 3.72%
6,262 $1.5 Million
Q1 2018

Apr 27, 2018

SELL
$205.46 - $240.27 $127,590 - $149,207
-621 Reduced 8.72%
6,504 $1.41 Million
Q4 2017

Jan 16, 2018

SELL
$189.0 - $222.64 $102,627 - $120,893
-543 Reduced 7.08%
7,125 $1.53 Million
Q3 2017

Oct 13, 2017

BUY
$186.89 - $198.9 $1.43 Million - $1.53 Million
7,668
7,668 $1.5 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Central Bank & Trust CO Portfolio

Follow Central Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Bank & Trust CO with notifications on news.